UK markets closed
  • FTSE 100

    +8.52 (+0.11%)
  • FTSE 250

    -248.86 (-1.24%)
  • AIM

    -4.39 (-0.47%)

    -0.0047 (-0.40%)

    -0.0108 (-0.90%)

    -1,930.34 (-9.70%)
  • CMC Crypto 200

    -36.52 (-6.74%)
  • S&P 500

    -55.26 (-1.29%)
  • DOW

    -292.30 (-0.86%)

    -0.42 (-0.46%)

    -10.50 (-0.59%)
  • NIKKEI 225

    -11.77 (-0.04%)

    +9.12 (+0.05%)
  • DAX

    -152.89 (-1.12%)
  • CAC 40

    -61.57 (-0.94%)

Edison Investment Research Limited: Agronomics (ANIC) Initiation - At the forefront of a new agrarian revolution

·3-min read

Edison Investment Research Limited
11-Jan-2022 / 07:00 GMT/BST


London, UK, 11 January 2021


Agronomics (ANIC) Initiation - At the forefront of a new agrarian revolution

Agronomics (ANIC) invests in companies producing environmentally friendly alternatives to traditionally produced meat, dairy, seafood, materials and other agricultural products. It aims to create long-term value for shareholders by investing mainly in private, early-stage companies and supporting them to sale, or public listing and commercial viability. ANIC is the only UK-listed vehicle targeting cellular agriculture, offering investors a rare opportunity to gain exposure to this exciting and rapidly expanding sector, which is likely to generate broad-based disruption to conventional agriculture. ANIC's strategy is supported by growing awareness of environmental issues. It has had an early mover advantage, possesses a reputation for expertise in the sector and has a level of access to follow-on and new investments unusual in the sector. Early performance has been promising and the company is trading at a premium to NAV. While it will take time for ANIC's investments to become commercially viable, significant valuation appreciation typically precedes large-scale commercialisation within the sector. And the valuations of more advanced, plant-based protein companies suggest the possibility of substantial long-term upside for patient investors.

ANIC's share price trades at a premium to cum-income NAV (using conservative, IFRS valuation methodology) thanks in part to its increasing popularity with investors and the scarcity of alternative investment options in the cellular agriculture sector. These factors, combined with a 'backward-looking' NAV, suggest the premium is likely to persist for the foreseeable future.

Click here to view the full report or here to sign up to receive research as it is published.


All reports published by Edison are available to download free of charge from its website

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Joanne Collins +44 (0)20 3077 5700

Sara Welford +44 (0)20 3077 5700

Learn more at and connect with Edison on: 




Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

End of Announcement - EQS News Service

show this
show this
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting